Insight Molecular Diagnostics (IMDX) Goodwill & Intangibles (2015 - 2025)

Insight Molecular Diagnostics (IMDX) has 10 years of Goodwill & Intangibles data on file, last reported at $15.0 million in Q3 2025.

• Quarterly Goodwill & Intangibles rose 3318.18% year-over-year to $15.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $15.0 million (up 3318.18% YoY) and the FY2024 annual result came in at $15.0 million, down 73.59% from the prior year.
• Goodwill & Intangibles grew to $15.0 million in Q3 2025 per IMDX's latest filing, from $14.6 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $113.4 million in Q1 2022, with the low at $440000.0 in Q2 2024.
• Average Goodwill & Intangibles over 5 years is $51.2 million, with a median of $56.9 million recorded in 2023.
• Year-over-year, Goodwill & Intangibles sank 99.33% in 2024 and soared 3318.18% in 2025.
• Insight Molecular Diagnostics' Goodwill & Intangibles stood at $80.4 million in 2021, then dropped by 11.9% to $70.8 million in 2022, then fell by 19.61% to $56.9 million in 2023, then sank by 73.59% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
• Business Quant data shows IMDX's Goodwill & Intangibles at $15.0 million in Q3 2025, $14.6 million in Q2 2025, and $440000.0 in Q1 2025.